Home MarketXLS
Dashboard MarketXLS
Screener MarketXLS
Options Profit Calculator MarketXLS
Stock Ranks MarketXLS
Spreadsheet Builder MarketXLS
Documentation MarketXLS
Logout MarketXLS
Bellicum Pharmaceuticals Inc. logo

Bellicum Pharmaceuticals Inc.

Sector: Healthcare   

Industry: Biotechnology

Optionable: No  Market Cap: 0 M  90-day average vol: 0

Previous close: 0.0801  Open: 0.0801  Bid:   Ask:
52 week range    
Last updated: Friday 21st June 2024

Get Access to 1 Billion Usable Market data points IN YOUR EXCEL SHEETS WITH EASY TO USE EXCEL FUNCTIONS

Get started today
Search for a stock

🎉 Exciting news! 🎉

You are invited to join our Discord Channel.

Interact, learn, and grow with experts in the markets!

Join our Discord


BLCM Income Statement

Invalid dateDec-15Dec-16Dec-17Dec-18Dec-19Dec-20Dec-21Dec-22
Basic EPS from continuing operations-24.4-240.1-1.34-0.84-0.81
Basic EPS total-24.4-240.1-1.34-0.84-0.81
Basic weighted shares outstanding3 M3 M32 M4 M468471.06 M12 M31 M
Cost of sales3 M580000.0864000.0436000.0
Depreciation-1 M-2 M-4 M-7 M-7 M2 M110000.010000.0
DepreciationAndAmortization-1 M-2 M-4 M-7 M-7 M2 M110000.010000.0
Diluted EPS total-18.4-25.7-2.89-24.4-240.1-1.34-0.84-0.81
Diluted normalized net income/share-0.84-0.81
Diluted weighted shares outstanding3 M3 M32 M4 M468471.06 M12 M31 M
GainOnSaleOfPPE-10000.00.04 M-478000.0
GeneralAndAdministrativeExpense13 M17 M21 M25 M30 M16 M7 M6 M
Gross operating profit-2 M717000.0376000.03 M8 M500000.06 M2 M
ImpairmentOfCapitalAssets42000.010000.0-11000.0-2 M1 M
Income before tax-49 M-69 M-92 M-98 M-112 M-7 M-10 M-25 M
Income taxes-32000.0-38 M-128000.0-5 M-10 M-3 M2000.0
Interest income387000.028000.046000.0
InterestExpenseNonOperating12000.02 M4 M4 M4 M3 M5000.0
MiscOtherSpecialCharges-2 M-10000.0-22 M46 M15 M2 M
Net income from total operations-49 M-69 M-92 M-98 M-112 M-8 M-10 M-25 M
NetIncomeCommonStockholders-49 M-69 M-92 M-98 M-112 M-7 M-10 M-25 M
NetIncomeContinuousOperations-49 M-69 M-92 M-98 M-112 M-8 M-10 M-25 M
NetNonOperatingInterestIncomeExpense-12000.0-2 M-4 M-4 M-4 M-2 M28000.046000.0
Operating income-48 M-67 M-86 M-94 M-86 M-52 M-25 M-27 M
Operating income before depreciation (EBITDA)-47 M-64 M-84 M-86 M-99 M-2 M-10 M-25 M
OperatingExpense-49 M-69 M-88 M97 M95 M55 M31 M28 M
Other income net302000.0-319000.02 M10000.022 M-50 M-15 M-2 M
OtherGandA13 M17 M21 M25 M30 M16 M7 M6 M
OtherOperatingExpenses-2 M1 M130000.0
RentAndLandingFees13 M17 M21 M0.0
Research & development expense34 M51 M66 M72 M65 M39 M24 M23 M
ResearchExpense34 M51 M66 M72 M65 M39 M24 M23 M
Revenue per share-422000.0-774000.0-886000.0-885000.0550000.016000.0
SalariesAndWages-8 M-12 M-14 M-14 M-7 M5 M
Selling Gen & administrative expense13 M17 M21 M25 M30 M16 M7 M6 M
Special income/charges-42000.0-10000.011000.02 M-1 M
Total Income available for interest expense (EBIT)-49 M-67 M-88 M-94 M-108 M-5 M-10 M-25 M
Total common shares outstanding3 M3 M34 M4 M504789.08 M9 M9 M
Total net income-49 M-69 M-92 M-98 M-112 M-8 M-10 M-25 M
Total ordinary shares10 M10 M10 M10 M10 M10 M10 M10 M
Total revenues923000.01 M1 M3 M8 M1000000.06 M2 M
TotalExpenses-46 M-68 M-87 M97 M95 M55 M31 M28 M
TotalRevenue282000.0388000.0185000.03 M8 M500000.06 M2 M
Call: 1-877-778-8358
Ankur Mohan MarketXLS
Welcome! I'm Ankur, the founder and CEO of MarketXLS. With more than ten years of experience, I have assisted over 2,500 customers in developing personalized investment research strategies and monitoring systems using Excel.

I invite you to book a demo with me or my team to save time, enhance your investment research, and streamline your workflows.
Implement “your own” investment strategies in Excel with thousands of MarketXLS functions and templates.

MarketXLS is a complete Excel stock solution

Kevin Hsu


I have used lots of stock and option information services. This is the only one which gives me what I need inside Excel

Lloyd Lenase

Option Day Trader

MarketXLS is a data junkie’s dream. It gives me the flexibility to mine for hidden treasures.


Swing trader since 2011

I like to access historical closing prices on a particular date. That makes tracking performance easy.

Patrick Cusatis, Ph.D., CFA

Associate Professor of Finance - Penn State University